WAYSTAR HOLDING CORP (WAY) Stock Fundamental Analysis

NASDAQ:WAY • US9467841055

25.65 USD
-0.37 (-1.42%)
At close: Feb 27, 2026
25.65 USD
0 (0%)
After Hours: 2/27/2026, 4:30:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to WAY. WAY was compared to 35 industry peers in the Health Care Technology industry. While WAY belongs to the best of the industry regarding profitability, there are concerns on its financial health. WAY has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year WAY was profitable.
  • In the past year WAY had a positive cash flow from operations.
  • WAY had negative earnings in 4 of the past 5 years.
  • In the past 5 years WAY always reported a positive cash flow from operatings.
WAY Yearly Net Income VS EBIT VS OCF VS FCFWAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 0 100M 200M 300M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 1.94%, WAY belongs to the top of the industry, outperforming 82.86% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 2.89%, WAY is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
  • WAY has a better Return On Invested Capital (2.93%) than 68.57% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for WAY is below the industry average of 6.63%.
  • The last Return On Invested Capital (2.93%) for WAY is above the 3 year average (2.33%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.94%
ROE 2.89%
ROIC 2.93%
ROA(3y)0.13%
ROA(5y)-0.34%
ROE(3y)-0.08%
ROE(5y)-0.98%
ROIC(3y)2.33%
ROIC(5y)1.82%
WAY Yearly ROA, ROE, ROICWAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 0 1 -1 2 -2 3

1.3 Margins

  • WAY's Profit Margin of 10.20% is amongst the best of the industry. WAY outperforms 94.29% of its industry peers.
  • With an excellent Operating Margin value of 22.75%, WAY belongs to the best of the industry, outperforming 94.29% of the companies in the same industry.
  • In the last couple of years the Operating Margin of WAY has grown nicely.
  • WAY has a Gross Margin of 68.33%. This is in the better half of the industry: WAY outperforms 68.57% of its industry peers.
  • WAY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 22.75%
PM (TTM) 10.2%
GM 68.33%
OM growth 3Y23.51%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.57%
GM growth 5YN/A
WAY Yearly Profit, Operating, Gross MarginsWAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so WAY is destroying value.
  • Compared to 1 year ago, WAY has more shares outstanding
  • Compared to 1 year ago, WAY has an improved debt to assets ratio.
WAY Yearly Shares OutstandingWAY Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 50M 100M 150M
WAY Yearly Total Debt VS Total AssetsWAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.2 Solvency

  • WAY has an Altman-Z score of 1.89. This is not the best score and indicates that WAY is in the grey zone with still only limited risk for bankruptcy at the moment.
  • WAY's Altman-Z score of 1.89 is in line compared to the rest of the industry. WAY outperforms 60.00% of its industry peers.
  • WAY has a debt to FCF ratio of 5.20. This is a neutral value as WAY would need 5.20 years to pay back of all of its debts.
  • WAY has a Debt to FCF ratio (5.20) which is in line with its industry peers.
  • A Debt/Equity ratio of 0.38 indicates that WAY is not too dependend on debt financing.
  • WAY has a Debt to Equity ratio of 0.38. This is in the lower half of the industry: WAY underperforms 68.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 5.2
Altman-Z 1.89
ROIC/WACC0.33
WACC8.85%
WAY Yearly LT Debt VS Equity VS FCFWAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 1B 2B 3B

2.3 Liquidity

  • WAY has a Current Ratio of 1.41. This is a normal value and indicates that WAY is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.41, WAY is not doing good in the industry: 62.86% of the companies in the same industry are doing better.
  • A Quick Ratio of 1.41 indicates that WAY should not have too much problems paying its short term obligations.
  • The Quick ratio of WAY (1.41) is worse than 62.86% of its industry peers.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 1.41
WAY Yearly Current Assets VS Current LiabilitesWAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 477.78% over the past year.
  • WAY shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.50%.
  • Measured over the past years, WAY shows a quite strong growth in Revenue. The Revenue has been growing by 15.97% on average per year.
EPS 1Y (TTM)477.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%24.14%
Revenue 1Y (TTM)16.5%
Revenue growth 3Y15.97%
Revenue growth 5YN/A
Sales Q2Q%24.35%

3.2 Future

  • Based on estimates for the next years, WAY will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.74% on average per year.
  • Based on estimates for the next years, WAY will show a quite strong growth in Revenue. The Revenue will grow by 10.60% on average per year.
EPS Next Y17.12%
EPS Next 2Y15.55%
EPS Next 3Y18.49%
EPS Next 5Y15.74%
Revenue Next Year17.8%
Revenue Next 2Y14.05%
Revenue Next 3Y12.94%
Revenue Next 5Y10.6%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
WAY Yearly Revenue VS EstimatesWAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B
WAY Yearly EPS VS EstimatesWAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 18.19, WAY is valued on the expensive side.
  • Based on the Price/Earnings ratio, WAY is valued a bit cheaper than 80.00% of the companies in the same industry.
  • WAY is valuated rather cheaply when we compare the Price/Earnings ratio to 27.11, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 15.53, the valuation of WAY can be described as correct.
  • WAY's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. WAY is cheaper than 77.14% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.13. WAY is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 18.19
Fwd PE 15.53
WAY Price Earnings VS Forward Price EarningsWAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of WAY indicates a somewhat cheap valuation: WAY is cheaper than 62.86% of the companies listed in the same industry.
  • WAY's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. WAY is cheaper than 74.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.33
EV/EBITDA 16.23
WAY Per share dataWAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • WAY has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as WAY's earnings are expected to grow with 18.49% in the coming years.
PEG (NY)1.06
PEG (5Y)N/A
EPS Next 2Y15.55%
EPS Next 3Y18.49%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • WAY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

WAYSTAR HOLDING CORP

NASDAQ:WAY (2/27/2026, 4:30:02 PM)

After market: 25.65 0 (0%)

25.65

-0.37 (-1.42%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-17
Earnings (Next)04-28
Inst Owners79.95%
Inst Owner Change6.16%
Ins Owners1.91%
Ins Owner Change-0.23%
Market Cap4.91B
Revenue(TTM)1.10B
Net Income(TTM)112.09M
Analysts83.85
Price Target37.5 (46.2%)
Short Float %4.61%
Short Ratio2.69
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.56%
Min EPS beat(2)-9.5%
Max EPS beat(2)4.39%
EPS beat(4)2
Avg EPS beat(4)-0.02%
Min EPS beat(4)-9.5%
Max EPS beat(4)6.31%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)2.92%
Min Revenue beat(2)2.25%
Max Revenue beat(2)3.6%
Revenue beat(4)4
Avg Revenue beat(4)3.04%
Min Revenue beat(4)2.25%
Max Revenue beat(4)3.95%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.34%
PT rev (3m)-5.68%
EPS NQ rev (1m)0.21%
EPS NQ rev (3m)-0.23%
EPS NY rev (1m)0%
EPS NY rev (3m)1.82%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)0.8%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.19%
Valuation
Industry RankSector Rank
PE 18.19
Fwd PE 15.53
P/S 4.46
P/FCF 17.33
P/OCF 15.85
P/B 1.27
P/tB N/A
EV/EBITDA 16.23
EPS(TTM)1.41
EY5.5%
EPS(NY)1.65
Fwd EY6.44%
FCF(TTM)1.48
FCFY5.77%
OCF(TTM)1.62
OCFY6.31%
SpS5.75
BVpS20.27
TBVpS-7.48
PEG (NY)1.06
PEG (5Y)N/A
Graham Number25.36
Profitability
Industry RankSector Rank
ROA 1.94%
ROE 2.89%
ROCE 4.49%
ROIC 2.93%
ROICexc 2.98%
ROICexgc 95.36%
OM 22.75%
PM (TTM) 10.2%
GM 68.33%
FCFM 25.76%
ROA(3y)0.13%
ROA(5y)-0.34%
ROE(3y)-0.08%
ROE(5y)-0.98%
ROIC(3y)2.33%
ROIC(5y)1.82%
ROICexc(3y)2.38%
ROICexc(5y)1.85%
ROICexgc(3y)62.49%
ROICexgc(5y)50.41%
ROCE(3y)3.57%
ROCE(5y)2.79%
ROICexgc growth 3Y48.7%
ROICexgc growth 5YN/A
ROICexc growth 3Y34.39%
ROICexc growth 5YN/A
OM growth 3Y23.51%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.57%
GM growth 5YN/A
F-Score6
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 5.2
Debt/EBITDA 3.73
Cap/Depr 18.84%
Cap/Sales 2.41%
Interest Coverage 3.06
Cash Conversion 79.27%
Profit Quality 252.65%
Current Ratio 1.41
Quick Ratio 1.41
Altman-Z 1.89
F-Score6
WACC8.85%
ROIC/WACC0.33
Cap/Depr(3y)15.22%
Cap/Depr(5y)12.68%
Cap/Sales(3y)2.67%
Cap/Sales(5y)2.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)477.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%24.14%
EPS Next Y17.12%
EPS Next 2Y15.55%
EPS Next 3Y18.49%
EPS Next 5Y15.74%
Revenue 1Y (TTM)16.5%
Revenue growth 3Y15.97%
Revenue growth 5YN/A
Sales Q2Q%24.35%
Revenue Next Year17.8%
Revenue Next 2Y14.05%
Revenue Next 3Y12.94%
Revenue Next 5Y10.6%
EBIT growth 1Y102.15%
EBIT growth 3Y43.22%
EBIT growth 5YN/A
EBIT Next Year58.23%
EBIT Next 3Y26.58%
EBIT Next 5Y16.82%
FCF growth 1Y98.73%
FCF growth 3Y49.24%
FCF growth 5YN/A
OCF growth 1Y82.41%
OCF growth 3Y44.5%
OCF growth 5YN/A

WAYSTAR HOLDING CORP / WAY FAQ

What is the fundamental rating for WAY stock?

ChartMill assigns a fundamental rating of 5 / 10 to WAY.


What is the valuation status of WAYSTAR HOLDING CORP (WAY) stock?

ChartMill assigns a valuation rating of 5 / 10 to WAYSTAR HOLDING CORP (WAY). This can be considered as Fairly Valued.


Can you provide the profitability details for WAYSTAR HOLDING CORP?

WAYSTAR HOLDING CORP (WAY) has a profitability rating of 7 / 10.


How financially healthy is WAYSTAR HOLDING CORP?

The financial health rating of WAYSTAR HOLDING CORP (WAY) is 3 / 10.


What is the expected EPS growth for WAYSTAR HOLDING CORP (WAY) stock?

The Earnings per Share (EPS) of WAYSTAR HOLDING CORP (WAY) is expected to grow by 17.12% in the next year.